Cargando…
Avoiding collateral mortality in a pandemic — time to change our mindset in surgical oncology
The coronavirus disease 19 (COVID-19) pandemic has become the focus of attention worldwide, and herein we seek to highlight the potential problem of ‘collateral mortality’ from delayed or deferred treatments in patients with cancer. We propose potential solutions to ensure continuity of care in the...
Autores principales: | Tan, Ker-Kan, Moran, Brendan J., Solomon, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199649/ https://www.ncbi.nlm.nih.gov/pubmed/32372035 http://dx.doi.org/10.1038/s41571-020-0383-1 |
Ejemplares similares
-
Avoiding a legacy of unequal non-communicable disease burden after the COVID-19 pandemic
por: Maani, Nason, et al.
Publicado: (2021) -
Yellow fever resurgence: An avoidable crisis?
por: Lindsey, Nicole P., et al.
Publicado: (2022) -
Oncology approvals in 2020: a year of firsts in the midst of a pandemic
por: Amiri-Kordestani, Laleh, et al.
Publicado: (2021) -
Our own petards
por: Petsko, Gregory A
Publicado: (2002) -
Our unhealthy nation
por: Green, Damian, et al.
Publicado: (2021)